DMK Pharmaceuticals Corporation filed a motion in the US Bankruptcy Court seeking the extension of its exclusivity periods on May 30, 2024. As per the motion, the debtor seeks to extend its exclusivity periods for both, to file a plan and to solicit votes on a plan, by 60 days i.e., up to August 2, 2024, and October 1, 2024, respectively. The debtor?s current exclusivity period and solicitation period would expire on June 3, 2024, and July 31, 2024, respectively.